Parkinson's disease MRI

Revision as of 18:35, 17 April 2018 by Fahimeh Shojaei (talk | contribs)
Jump to navigation Jump to search

Parkinson's disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Parkinson's disease from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Neurocognitive Disorder Due to Parkinson's Disease

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Parkinson's disease MRI On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Parkinson's disease MRI

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Parkinson's disease MRI

CDC on Parkinson's disease MRI

Parkinson's disease MRI in the news

Blogs on Parkinson's disease MRI

Directions to Hospitals Treating Parkinson's disease

Risk calculators and risk factors for Parkinson's disease MRI

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

MRI

Diagnosis of parkinson disease is mostly clinical but there are some MRI finding supporting the diagnosis. In the STN of PD patients there are increased amount of iron. The excess iron will cause a reduction in T2 relaxation time and it’s more prominent in one side.[1] There are also evidence of reduced iron content in putamen and GPe.[2][3] we can also use MRI to differentiate PD from other conditions. for example in the midbrain, thinning of anteroposterior diameter and enlargement of third ventricle in suggestive of supranuclear palsy.[4][5] Also we can see atrophy of brainstem and cerebellum in multiple system atrophy.[6][7]

References

  1. Kosta P, Argyropoulou MI, Markoula S, Konitsiotis S (January 2006). "MRI evaluation of the basal ganglia size and iron content in patients with Parkinson's disease". J. Neurol. 253 (1): 26–32. doi:10.1007/s00415-005-0914-9. PMID 15981079.
  2. Graham JM, Paley MN, Grünewald RA, Hoggard N, Griffiths PD (December 2000). "Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence". Brain. 123 Pt 12: 2423–31. PMID 11099445.
  3. Ryvlin P, Broussolle E, Piollet H, Viallet F, Khalfallah Y, Chazot G (June 1995). "Magnetic resonance imaging evidence of decreased putamenal iron content in idiopathic Parkinson's disease". Arch. Neurol. 52 (6): 583–8. PMID 7763206.
  4. Stern MB, Braffman BH, Skolnick BE, Hurtig HI, Grossman RI (November 1989). "Magnetic resonance imaging in Parkinson's disease and parkinsonian syndromes". Neurology. 39 (11): 1524–6. PMID 2812334.
  5. Asato R, Akiguchi I, Masunaga S, Hashimoto N (2000). "Magnetic resonance imaging distinguishes progressive supranuclear palsy from multiple system atrophy". J Neural Transm (Vienna). 107 (12): 1427–36. doi:10.1007/s007020070006. PMID 11458995.
  6. Konagaya M, Konagaya Y, Iida M (December 1994). "Clinical and magnetic resonance imaging study of extrapyramidal symptoms in multiple system atrophy". J. Neurol. Neurosurg. Psychiatry. 57 (12): 1528–31. PMC 1073237. PMID 7798985.
  7. Yekhlef F, Ballan G, Macia F, Delmer O, Sourgen C, Tison F (February 2003). "Routine MRI for the differential diagnosis of Parkinson's disease, MSA, PSP, and CBD". J Neural Transm (Vienna). 110 (2): 151–69. doi:10.1007/s00702-002-0785-5. PMID 12589575.

Template:WH Template:WS